Literature DB >> 8108464

Progesterone and estradiol interaction in the regulation of rat uterine weight and estrogen receptor concentration.

K L Medlock1, T M Forrester, D M Sheehan.   

Abstract

Autologous down-regulation of hormone receptors has been shown for several steroid hormones. We have previously shown estradiol (E2) regulates estrogen receptor (ER) in ovariectomized (OVX) rats. These studies have been extended to investigate the interaction between progesterone (P) and E2 in the regulation of ER and uterine weight. We implanted Silastic capsules containing varying concentrations of E2 (0.0005 mg E2/ml to 5.0 mg E2/ml of sesame oil) into adult female Sprague-Dawley rats one week after OVX. Simultaneously with implantation, P injections were started (sc in sesame oil) at doses of 1-40 mg/day for three days. In the absence of P, the 0.05 mg E2/ml implant significantly increased total ER levels (measured by cytosol and nuclear exchange assays) by 25%, while the two highest concentrations of E2 (0.5 and 5.0 mg E2/ml) significantly decreased cytosol and total ER levels by at least 40%. No P dose altered ER levels in OVX rats or in rats given E2 implants of 0.01 mg E2/ml or lower. At E2 implant concentrations of 0.05 mg E2/ml and higher, P decreased total ER levels 30%-50% compared to the appropriate E2-only controls. P increased uterine weight by 25% in OVX controls and in rats treated with E2 implants of 0.01 mg E2/ml and below. In contrast, P inhibited uterine weight gain induced by 0.05-5.0 mg/E2 ml implants by 20%-30%; maximal inhibition occurred at 5 mg/day of P and above. These data demonstrate that P increases uterine weight but does not alter ER concentration in rats with low E2 levels (OVX or low E2 concentration implants) but decreases uterine weight and down-regulates ER at higher E2 levels, regardless of whether ER is up-regulated or down-regulated by E2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8108464     DOI: 10.3181/00379727-205-43690

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  8 in total

1.  Oestrogen-dependent expression of the SM2 smooth muscle-type myosin isoform in rabbit myometrium.

Authors:  A Capriani; A Chiavegato; R Franch; G Azzarello; O Vinante; S Sartore
Journal:  J Muscle Res Cell Motil       Date:  1997-08       Impact factor: 2.698

2.  Effects of progesterone treatment on expression of genes involved in uterine quiescence.

Authors:  Melvyn S Soloff; Yow-Jiun Jeng; Michael G Izban; Mala Sinha; Bruce A Luxon; Susan J Stamnes; Sarah K England
Journal:  Reprod Sci       Date:  2011-08       Impact factor: 3.060

Review 3.  Reproductive consequences of developmental phytoestrogen exposure.

Authors:  Wendy N Jefferson; Heather B Patisaul; Carmen J Williams
Journal:  Reproduction       Date:  2012-01-05       Impact factor: 3.906

4.  Estradiol and progesterone modulate spontaneous sleep patterns and recovery from sleep deprivation in ovariectomized rats.

Authors:  Samüel Deurveilher; Benjamin Rusak; Kazue Semba
Journal:  Sleep       Date:  2009-07       Impact factor: 5.849

5.  Developmental and Reproductive Effects of SE5-OH: An Equol-Rich Soy-Based Ingredient.

Authors:  Ray A Matulka; Ikuo Matsuura; Tohru Uesugi; Tomomi Ueno; George Burdock
Journal:  J Toxicol       Date:  2008-12-15

Review 6.  Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative.

Authors:  Harry A van Diepen
Journal:  Reprod Biol Endocrinol       Date:  2012-10-08       Impact factor: 5.211

7.  Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway.

Authors:  Gudmundur Thordarson; Nicole Slusher; Harriet Leong; Dafne Ochoa; Lakshmanaswamy Rajkumar; Raphael Guzman; Satyabrata Nandi; Frank Talamantes
Journal:  Breast Cancer Res       Date:  2004-06-04       Impact factor: 6.466

8.  Topical estrogen application promotes cutaneous wound healing in db/db female mice with type 2 diabetes.

Authors:  Kanae Mukai; Shin-Ichi Horike; Makiko Meguro-Horike; Yukari Nakajima; Arya Iswara; Toshio Nakatani
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.